Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive Disease.
Journal: The Urologic clinics of North America
Published: June 26, 2026
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026).
Journal: The Journal of urology
Published: April 16, 2026
Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab.
Journal: European urology oncology
Published: March 20, 2026
Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.
Journal: The Journal of urology
Published: March 17, 2026
Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer.
Journal: Science (New York, N.Y.)
Published: March 12, 2026
Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder Cancer.
Journal: Clinical genitourinary cancer
Published: December 17, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer.
Journal: Nature communications
Published: July 02, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.
Journal: JCO precision oncology
Published: May 01, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
Journal: The oncologist
Published: March 08, 2024
Last Updated: 09/26/2026